Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms.

BMC research notes - 23 Aug 2014

KayvanJoo Amir Hossein, Ebrahimi Mansour, Haqshenas Gholamreza

Abstract excerpt

BACKGROUND: Hepatitis C virus (HCV) causes chronic hepatitis C in 2-3% of world population and remains one of the health threatening human viruses, worldwide. In the absence of an effective vaccine, therapeutic approach is the only option to combat hepatitis C. Interferon-alpha (IFN-alpha) and ribavirin (RBV) combination alone or in combination with recently introduced new direct-acting antivirals (DAA) is used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine Nucleotides
Share to Artificial Intelligence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Support Techniques

Share to Decision Trees

Share to Guanine Nucleotides

Share to Hydrogen

Share to Interferons

Share to Patient Selection

Source

Open in PubMed Open full text

Identifiers

PMID: 25150834
DOI: 10.1186/1756-0500-7-565
PMCID: PMC4246553

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms.PMID 25150834Read ↗

Prediction of prognostic biomarkers for interferon-based therapy to hepatitis C virus patients: a meta-analysis of the NS5A protein in subtypes 1a, 1b, and 3a.Semantic proximity Read ↗

A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus.Semantic proximity Read ↗

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.Semantic proximity Read ↗

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.Semantic proximity Read ↗

Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients.Semantic proximity Read ↗

A Multi-Biomarker Prediction Model Integrating Genetics, Hematological Indices, and Fibrosis Stage to Forecast Non-Response in HCV Genotype 4Semantic proximity Read ↗

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.Semantic proximity Read ↗

Pred-AHCP: Robust feature selection enabled Sequence-Specific Prediction of Anti-Hepatitis C Peptides via Machine LearningSemantic proximity Read ↗

Optimum predictors of therapeutic outcome in HCV patients in Pakistan.Semantic proximity Read ↗

Predictors of hepatitis C treatment response: what's new?Semantic proximity Read ↗

Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.Semantic proximity Read ↗

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.